Skip to main content
. 2021 Jun 9;12(6):e00363. doi: 10.14309/ctg.0000000000000363

Figure 2.

Figure 2.

Proposed SARS-CoV-2 assessments for potential feces donors before the release of material for FMT. Outlining initial screening questionnaire for exposures and symptoms for COVID-19 (a), followed by initial nasopharyngeal and stool testing of SARS-CoV-2 (b), followed by banking and storage of aliquots for SARS-CoV-2 testing of each sample for less than 60 days (c), followed by release of SARS-CoV-2 nasopharyngeal, and stool testing 2–4 weeks after last stool donation. Figure created with Biorender.com. COVID-19, Coronavirus 2019; FMT, fecal microbiota transplant; NP, Nasopharyngeal; RT-PCR, Reverse transcriptase polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.